Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.000
-0.050 (-1.23%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Lifecore Biomedical Revenue
Lifecore Biomedical had revenue of $35.75M in the quarter ending December 31, 2025, with 9.77% growth. This brings the company's revenue in the last twelve months to $128.87M, down -1.52% year-over-year. In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth.
Revenue (ttm)
$128.87M
Revenue Growth
-1.52%
P/S Ratio
1.16
Revenue / Employee
$338,913
Employees
382
Market Cap
149.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 25, 2025 | 128.87M | 606.00K | 0.47% |
| May 26, 2024 | 128.26M | 24.99M | 24.20% |
| May 28, 2023 | 103.27M | -8.00M | -7.19% |
| May 29, 2022 | 111.27M | 10.40M | 10.31% |
| May 30, 2021 | 100.87M | -59.19M | -36.98% |
| May 31, 2020 | 160.07M | -397.49M | -71.29% |
| May 26, 2019 | 557.56M | 33.33M | 6.36% |
| May 27, 2018 | 524.23M | 54.45M | 11.59% |
| May 28, 2017 | 469.78M | -7.14M | -1.50% |
| May 29, 2016 | 476.92M | -62.34M | -11.56% |
| May 31, 2015 | 539.26M | 62.44M | 13.10% |
| May 25, 2014 | 476.81M | 35.11M | 7.95% |
| May 26, 2013 | 441.71M | 124.16M | 39.10% |
| May 27, 2012 | 317.55M | 40.82M | 14.75% |
| May 29, 2011 | 276.73M | 44.64M | 19.23% |
| May 30, 2010 | 232.09M | 3.54M | 1.55% |
| May 31, 2009 | 228.55M | -2.64M | -1.14% |
| May 25, 2008 | 231.19M | 25.76M | 12.54% |
| May 27, 2007 | 205.43M | -23.70M | -10.34% |
| May 28, 2006 | 229.13M | 24.41M | 11.92% |
| May 29, 2005 | 204.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 564.17M |
| Evolus | 297.18M |
| Aurora Cannabis | 272.13M |
| Organigram Global | 204.21M |
| Assertio Holdings | 118.71M |
| Anika Therapeutics | 112.82M |
| SIGA Technologies | 94.57M |
| Journey Medical | 59.40M |
LFCR News
- 1 day ago - Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company - GlobeNewsWire
- 8 days ago - Lifecore Biomedical Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 8 days ago - Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update - GlobeNewsWire
- 14 days ago - Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum - GlobeNewsWire
- 15 days ago - Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 - GlobeNewsWire
- 20 days ago - Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment - GlobeNewsWire
- 5 weeks ago - Lifecore Biomedical to Participate at DCAT Week 2026 - GlobeNewsWire